Fred Hutchinson Cancer Center

Fred Hutch Cancer Center provides the latest cancer treatment options and is known for breakthroughs impacting both cancer and infectious diseases worldwide. Fred Hutch is an independent organization that also serves as the cancer program for UW Medicine. To learn more, visit: https://www.fredhutch.org/en.html

For the latest Fred Hutch oncology educational events click here.


 

Myeloma

AML - Keynote - Latest updates on Standard Therapies and Investigational Therapies, MRD in AML, HTC and Non-HCT

Playlist Items:
ASH 2018 AML: Deciding Between Standard vs Investigational Therapies & Problems in Evaluating New Therapies, MRD and HCT, The University of Kansas Cancer Center
ASH December 2018 - MRD in AML - What is the Benefit / Risk Ratio Related to HCT?, The University of Kansas Cancer Center
ASH December 2018 - AML - Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies, The University of Kansas Cancer Center
ASH 2018 AML Challenges in Evaluating New Therapies: Understanding the Recent FDA Approvals, The University of Kansas Cancer Center
  • 459 views
  • March 19, 2019